TSPO and depressive symptom measurement: The finding of significantly higher TSPO binding in depressed subjects even after correcting for BMI again suggests that a peripheral metabolic–immune dysfunction per se is not sufficient to induce increase in TSPO expression or development of depression, and other factors, such as blood-brain barrier permeability, may be relevant for a better understanding of the link between peripheral metabolic–immune dysfunction and depression.